Transvaginal sonographic features of diffuse adenomyosis in 18-30-year-old nulligravid women without endometriosis: association with symptoms
Observational
OA: closed
CC0
⤵ 141 in-corpus citations
AI-generated summary
This study investigated transvaginal sonographic features of diffuse adenomyosis in young nulligravid women, finding they are associated with dysmenorrhea and abnormal uterine bleeding.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVES: To investigate whether there are sonographic features of diffuse adenomyosis in 18-30-year-old nulligravid women without endometriosis and to examine their association with symptoms of dysmenorrhea and abnormal uterine bleeding.
METHODS: This was a prospective observational study including women referred from a gynecology outpatient center to our university hospital for ultrasound examination. Inclusion criteria were age between 18 and 30 years, regular menstrual cycle and nulligravid status. Exclusion criteria were a past or current history of endometriosis, fibroids, ovarian cysts or lesions, endometrial pathology, current use of hormonal treatments or medications that would affect the menstrual cycle, previous uterine surgery and history of infertility. Women underwent a detailed clinical assessment and a two- (2D) and three-dimensional (3D) transvaginal ultrasound (TVS) examination. 2D-TVS features associated with diffuse adenomyosis were predefined as: (1) heterogeneous myometrium; (2) hypoechoic striation in the myometrium; (3) myometrial anechoic lacunae or cysts; (4) asymmetrical myometrial thickening of the uterine walls with the presence of straight vessels, extending into the hypertrophic myometrium, on power Doppler examination. On 3D-TVS, endomyometrial junctional zone (JZ) was measured as the distance from the basal endometrium to the internal layer of the outer myometrium on coronal section at any level of the uterus, and the smallest (JZmin) and largest (JZmax) JZ thicknesses and their difference (JZdiff) were recorded. 3D-TVS evaluation was considered suggestive for adenomyosis when JZmax ≥ 8 mm and/or JZdiff ≥ 4 mm. The presence of associated symptomatology represented our main outcome: the amount of menstrual loss was assessed by a pictorial blood loss analysis chart (PBAC) and painful symptoms were evaluated using a visual analog scale (VAS).
RESULTS: During the observation period, 205 women (median age, 24 (interquartile range, 23-27) years) were enrolled into the study and 156 met the inclusion criteria. According to the 2D-TVS criteria, diffuse adenomyosis was found in 53 (34.0%) women and asymmetrical myometrial thickening of the uterine walls was the most common sonographic feature observed. ANOVA showed a significant relationship between the number of 2D-TVS features of diffuse adenomyosis and VAS score for dysmenorrhea (P = 0.005) as well as PBAC score for menstrual loss (P = 0.03). 3D-TVS showed that women with 2D-TVS features of diffuse adenomyosis had a significantly higher value of JZmax (6.38 ± 2.30 mm, P < 0.001), JZmin (2.07 ± 0.43 mm, P = 0.002) and JZdiff (4.33 ± 1.99 mm, P < 0.001) than did women without these features. Women with sonographic features of diffuse adenomyosis were symptomatic in 83% of cases, reported dysmenorrhea in 79.2% and showed a higher incidence of heavy bleeding than did those without these features (18.9% vs 2.9%; P = 0.001).
CONCLUSIONS: Sonographic features suggestive of diffuse adenomyosis may develop earlier in reproductive life than previously thought, and may occur in association with dysmenorrhea and abnormal uterine bleeding in nulligravid women. Their observation in these women should therefore warrant further gynecological investigation.
My notes (saved in your browser only)
Outcome instruments
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (28)
- Adenomyosis as a disorder of the early and late human reproductive period via openalex
- Adenomyosis at hysterectomy: a study on frequency distribution and patient characteristics via openalex
- Adenomyosis:common and uncommon manifestations on sonography and magnetic resonance imaging via openalex
- Adenomyosis: review of the literature via openalex
- Adenomyosis: sonographic findings and diagnostic accuracy via openalex
- Adenomyosis: US features with histologic correlation in an in-vitro study via openalex
- Duration of dysmenorrhoea and extent of adenomyosis visualised by magnetic resonance imaging via openalex
- FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age via openalex
- How common is adenomyosis? A prospective study of prevalence using transvaginal ultrasound in a gynaecology clinic via openalex
- Infertility and adenomyosis via openalex
- Is adenomyosis associated with menorrhagia? via openalex
- Magnetic resonance imaging and transvaginal ultrasonography for the diagnosis of adenomyosis via openalex
- MR imaging of the uterus and cervix in healthy women: determination of normal values via openalex
- Predictive value of magnetic resonance imaging in differentiating between leiomyoma and adenomyosis via openalex
- Preoperative and Postoperative Clinical and Transvaginal Ultrasound Findings of Adenomyosis in Patients With Deep Infiltrating Endometriosis via openalex
- Prevalence and risk factors of adenomyosis at hysterectomy via openalex
- Risk factors for adenomyosis via openalex
- Structural and molecular features of the endomyometrium in endometriosis and adenomyosis via openalex
- The elusive adenomyosis of the uterus--revisited via openalex
- The pathophysiology of uterine adenomyosis: an update via openalex
- The symptomatology of adenomyosis via openalex
- Transvaginal sonography in the diagnosis of adenomyosis: which findings are most accurate? via openalex
- Transvaginal ultrasound or MRI for diagnosis of adenomyosis via openalex
- Ultrasonography compared with magnetic resonance imaging for the diagnosis of adenomyosis: correlation with histopathology via openalex
- W2014463766 via openalex
- W2123738482 via openalex
- W2056479931 via openalex
- W2087831276 via openalex
Cited by (50)
- Adenomyosis, Infertility and Maternal-Fetal Outcomes: Diagnostic and Therapeutic Strategies Across Disease Phenotype-A Narrative Review 2026
- Clinical efficacy and safety of subtotal resection of adenomyotic lesions based on the Kishi classification: a retrospective case series study 2026
- Role of oral gonadotropin-releasing hormone antagonists in the management of uterine adenomyosis: a narrative review 2026
- 3D and 4D Ultrasound of Adenomyosis 2026
- Effect of focal adenomyosis on pregnancy outcomes: retrospective propensity score matching analysis of 13,186 IVF/ICSI cycles 2026
- Coexisting adenomyosis in endometriosis: Similar pain and quality of life, with longer bleeding and bowel symptoms-A comparative cross-sectional study 2026
- The interaction between inflammation and estrogen in adenomyosis : from molecular mechanisms to therapeutic strategies 2026
- A hypothesis on the aetiology of adenomyosis: is there an association between cumulative number of menstruations and severity of adenomyosis on ultrasound? 2026
- Prediction of Anemia in Adenomyosis Patients Using Transvaginal Ultrasound Radiomics 2026
- Spatial transcriptomics uncovers the hybrid molecular identity, ciliated phenotype, and immune signature of adenomyosis lesions 2026
- The effects of endometrial polyps, leiomyomas, adenomyosis, and endometriosis on endometrial receptivity: phenotype, molecular pathways, and clinical implications 2026
- The relationship between symptoms of adenomyosis and current ultrasonographic diagnostic criteria 2026
- Transvaginal Sonographic Features of Diffuse Adenomyosis and Associated Symptoms in 18-30-Year-Old Nulligravid Women Without Endometriosis: Is Our Diagnosis Still Valid 10 Years Later? A Re-Evaluation of Previous Results 2026
- Drug development for adenomyosis based on pathophysiology 2025
- Adenomyosis and coexisting gynecologic pathologies: How often do they coexist? 2025
- Different prophylactic measures for preventing postoperative deep venous thromboembolism in adenomyosis: a retrospective study 2025
- Progressively diminished estrogen signaling concordant with increased fibrosis in ectopic endometrium 2025
- Spatial and single-cell transcriptomics landscape of adenomyosis 2025
- A holistic and individualised homoeopathic approach to adenomyosis – A case report 2025
- Focal Adenomyosis and Uterine Junctional Zone Abnormalities: Predictors of Live Birth Rates in Women with Infertility and Adenomyosis Undergoing Assisted Reproduction Technologies 2025
- Efficacy and safety of relugolix combination therapy in women with uterine fibroids and adenomyosis: subgroup analysis of LIBERTY 1 and LIBERTY 2 2025
- Updates on adenomyosis and fertility 2025
- Temporal dynamics of uterine immune microenvironment remodeling in a murine model of adenomyosis 2025
- Ultrasound Elastography in Benign Gynecology: A Scoping Review 2024
- Connecting the Dots on Female Digital Health Education: A Systematic Review 2024
- Internal and external adenomyosis phenotypes: ultrasound features and association with clinical outcomes 2024
- The Microbiome Landscape of Adenomyosis: A Systematic Review 2024
- Diagnostic Accuracy of Ultrasound in the Diagnosis of Adenomyosis 2024
- Adenomyosis and endometriosis in adolescents and young women with pelvic pain: prevalence and risk factors 2024
- Effect of Treatment with Progestins and Antiplatelet Agents on IVF in Women with Adenomyosis and Recurrent Implantation Failure 2024
- Value of serum muscular creatinine phosphokinase levels in patients with adenomyosis as a non-invasive diagnostic marker 2024
- Endometriosis and Adenomyosis 2024
- Risk factors for symptom recurrence after microwave ablation of adenomyosis: a preliminary retrospective study 2024
- Comparison of uterine transcornual diameter using 3D-transvaginal ultrasound between adenomyotic and normal uteri 2024
- Society of Endometriosis and Uterine Disorders forum: adenomyosis today, Paris, France, December 12, 2023 2024
- Prevalence of adenomyosis features in women scheduled for assisted reproductive treatment, using the Morphological Uterus Sonographic Assessment group definitions 2024
- The Role of Different Medical Therapies in the Management of Adenomyosis: A Systematic Review and Meta-Analysis 2024
- Imaging and molecular features of adenomyosis after menopause 2024
- Current Trends and Future Strategies on Diagnosis and Management of Adenomyosis: An Updated Review 2024
- Adenomyosis and Abnormal Uterine Bleeding: Review of the Evidence 2024
- Overview of crosstalk between stromal and epithelial cells in the pathogenesis of adenomyosis and shared features with deep endometriotic nodules 2024
- Prevalence of adenomyosis in symptomatic adolescents and young women: a systematic review and meta-analysis 2024
- Adenomyosis-a rare cause of chronic lumbago in adolescents 2023
- Pseudo-invasive Vasculocentric Adenomyosis- A Diagnostic Dilemma 2023
- Tumor rupture and partial gut obstruction: Atypical presentations in a patient with adenomyosis 2023
- Guideline No. 437: Diagnosis and Management of Adenomyosis 2023
- Radiofrequency Ablation for Adenomyosis 2023
- Reproductive outcome and gynecologic comorbidities in women with endometriosis in a non-IVF setting: a retrospective study 2023
- [Directive clinique no 437 : Diagnostic et prise en charge de l'adénomyose] 2023
- Adenomiosis: diagnóstico 2023
Source provenance
- europepmc
- last seen: 2026-10-15T06:08:49.021275+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:15:04.544443+00:00
- unpaywall
- last seen: 2026-10-15T06:24:24.424788+00:00
License: CC0
· commercial use OK